42 U.S. Code § 289g–3 - Breast implant research

prev | next
(a) In general
The Director of NIH may conduct or support research to examine the long-term health implications of silicone breast implants, both gel and saline filled. Such research studies may include the following:
(1) Developing and examining techniques to measure concentrations of silicone in body fluids and tissues.
(2) Surveillance of recipients of silicone breast implants, including long-term outcomes and local complications.
(b) Definition
For purposes of this section, the term “breast implant” means a breast prosthesis that is implanted to augment or reconstruct the female breast.


(July 1, 1944, ch. 373, title IV, § 498C, as added Pub. L. 107–250, title II, § 215(b),Oct. 26, 2002, 116 Stat. 1615.)
Breast Implants; Study by Comptroller General

Pub. L. 107–250, title II, § 214,Oct. 26, 2002, 116 Stat. 1615, which provided that the Comptroller General was to conduct a study of information typically provided by health professionals to women on breast implant surgery and to report the findings of the study to Congress, was repealed by Pub. L. 111–8, div. G, title I, § 1301(g),Mar. 11, 2009, 123 Stat. 829.

This is a list of parts within the Code of Federal Regulations for which this US Code section provides rulemaking authority.

This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].

It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.

42 CFR - Public Health



LII has no control over and does not endorse any external Internet site that contains links to or references LII.